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Abstract
Purpose Most knowledge regarding outcome after adrenal
surgery stems from retrospective studies reported by highly
specialized centres. The aim of this study was to report a
national experience of adrenalectomy with particular attention
to predictive factors for postoperative complications, conver-
sion from endoscopic to open surgery and length of hospital
stay.
Methods Adrenalectomies reported in the Scandinavian
Quality Register for Thyroid, Parathyroid and Adrenal
Surgery (SQRTPA) 2009–2014 were included. Risk factors
for complications, conversion and hospital stay >3 days were
assessed using univariable and multivariable logistic regres-
sion analysis.
Results There were 659 operations. Endoscopic adrenalecto-
my was performed in 513 (77.8%) operations and almost half
of these were robotic assisted. The median length of hospital
stay was 3 (range 1–30) days. There was no 30-day mortality.
In 43 (6.6%) patients, at least one complication was registered.
The only factor associated with complications in multivariable
analysis was conversion to open surgery odds ratio (OR) 3.61
(95% confidence interval 1.07 to 12.12). The risk for conver-
sion was associated with tumour size OR 1.03 (1.00 to 1.06)
and with malignancy on histopathology OR 8.33 (2.12 to
32.07). Length of hospital stay increased in patients with op-
eration of bilateral tumours OR 3.13, left-sided tumours OR
1.98, hyper secretion of catecholamines OR 2.32, conversion
to open surgery OR 42.05 and open surgery OR 115.18.
Conclusions The present study shows that endoscopic sur-
gery is widely used. Complications were associated with con-
version and the risk for conversion was associated with tu-
mour size and malignant tumour. Hospital stay was short.
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Introduction
Adrenalectomies are becoming more frequent worldwide.
Contemporary imaging techniques with an increased detec-
tion of adrenal incidentalomas and new surgical techniques
with reduction of morbidity and mortality with endoscopic
methods [1, 2] have contributed to the increase in operations.
In 1992, Gagner et al. were among the first to describe lapa-
roscopic adrenalectomy [3]. Since then, several studies have
evaluated minimally invasive surgery for adrenal lesions,
which has become the standard technique for surgical treat-
ment of adrenal tumours [4, 5]. Previous studies have com-
pared laparoscopic with open adrenalectomy for complica-
tions, hospital stay, morbidity and mortality [2, 6, 7].
Laparoscopic adrenalectomy is widely used in both university
hospitals and smaller units. Studies have evaluated risk factors
for complications associated with surgical technique, surgeon
volume and patient-related risk factors. Most of the studies are
single-centre studies [8–10], although a few national studies
that included specific hospitals or patient groups are available
[11–13].
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Adrenalectomies in Sweden have been registered in the
Scandinavian Quality Register for Thyroid, Parathyroid and
Adrenal Surgery (SQRTPA) as of 2009. All hospitals that
perform adrenal surgery are participating in the registry. The
aim of the present study was to evaluate a national experience
of adrenal surgery over 6 years and to determine risk factors
for complications, conversion from endoscopic to open sur-
gery and prolonged hospital stay.
Material and methods
Register background
The SQRTPA was established 2004. In 2009, a module for
adrenal surgery was added. The register is an online database
and is recognized by the Swedish National Board of Health
and Welfare as the national registry within the field.
Patients who underwent adrenal surgery and were reported
in the registry 2009–2014 were included in the study. All
procedures were performed by endocrine surgeons. Follow-
up was performed at 4–6 weeks postoperatively.
Data variables
Data were collected for age, gender, body mass index (BMI),
hypertension, radiographic tumour size (largest diameter mea-
sured on adrenal-CT or MRI), side for adrenal tumour, indi-
cation for surgery, surgical technique, histopathology, conver-
sion rate from endoscopic to open surgery, complications
(bleeding with transfusion, laceration of viscus, pneumotho-
rax, local infection/abscess and re-operation), postoperative
length of stay and 30-day mortality.
Surgical techniques were grouped for the analysis.
Endoscopic adrenalectomy included laparoscopic adrenalec-
tomy (posterior and transabdominal) and robotic-assisted lap-
aroscopic adrenalectomy (posterior and transabdominal).
Open adrenalectomy included laparotomy, thoracoabdominal
approach and open retroperitoneal operations. The technique
used was determined by the surgeon on the basis of preoper-
ative findings, availability of equipment and surgical
experience.
The primary outcomes were risk factors affecting conver-
sion rate, complication rate and postoperative length of stay
(LOS).
The secondary outcomes were variables associated with a
surgical technique, laparoscopic, versus robot-assisted adre-
nalectomy and endoscopic versus open adrenalectomy.
Statistical analysis
Descriptive statistics are presented as number with valid per
cent or median with minimum and maximum values. Binary
logistic regression was used to analyse the association be-
tween outcome variables and predictors. Analysed outcome
variables were complication (defined as bleeding with trans-
fusion, laceration of viscus, pneumothorax, local infection or
abscess and re-operation (no or yes)), re-operation (no or yes),
conversion (no or yes), postoperative days before discharge
(1–3 and 4–30), technique (endoscopic, open) and technique
(laparoscopic, robotic). The predictors that were assessed
were age, sex, BMI (less than 25 or 25 and higher), adrenal
tumour side (right or left or bilateral), largest tumour size,
surgical technique (laparoscopic, robotic, open), clinical syn-
drome of hormonal excess (none, cathecholamines, cortisol
and subclinical Cushing syndrome, aldosterone), histopathol-
ogy (malignant, phaeochromocytoma, other benign lesions)
and conversion from endoscopic to open surgery (no or yes).
Univariable analyses were conducted, and each outcome var-
iable was assessed with each predictor. Forward multiple lin-
ear regression analyses were performed to identify models
with significant predictors for each outcome variable, except
for re-operation due to small numbers of events. The results
from the binary logistic regressions are shown as numbers,
odds ratios with 95% confidence intervals (CI) and p values.
All analyses were conducted using IBM SPSS Statistics 22
for Windows (IBM Corporation, Armonk, NY, USA). We
considered p values below 0.05 as statistically significant.
Results
Some 659 patients underwent adrenalectomy under the 6-year
period in ten surgical departments. The distribution between
centres is shown in Table 1. Preoperative characteristics of the
cohort are summarized in Table 2.
The median age was 59 (range 8–89) years, and 372
(56.4%) patients were women. Some 215 (32.6%) patients
had hypertension defined as blood pressure >140/90 mmHg.
On radiological examination, the median size of the tumour
was 35 mm (range 1–200).
Indication for operation could be one or several. The most
common indication was a clinical syndrome of hormonal ex-
cess; 161 (24.4%) patients had hormonal excess of aldoste-
rone, 113 (17.1%) patients had hypersecretion of
cathecholamines , and 118 (17.9%) pat ients had
hypercortisolism. In 215 (32.6%) patients, malignancy was
suspected on the basis of radiological examination (CT or
MRI). Some 32 (4.9%) patients had preoperatively diagnosed
metastases and 75 (11.4%) patients underwent surgery be-
cause of a tumour size larger than 40 mm.
Perioperative characteristics are shown in Table 3. Final
pathologic diagnosis was, among others, adrenal cortical ade-
noma in 262 (49.6%) patients and phaeochromocytoma in 100
(18.9%) patients. In total, 71 (13.3%) patients had a diagnosis
of malignancy.
316 Langenbecks Arch Surg (2017) 402:315–322
Endoscopic adrenalectomy was performed in 513 (77.8%)
patients and almost half of these operations were robotically
assisted. In total, 146 (22.2%) patients were operated with
open procedures and in 37 (5.6%) patients, conversion was
performed from endoscopic to open surgery.
Some 43 (6.5%) patients had a complication and the most
common was bleeding with transfusion. The 30-day mortality
rate was nil. Median LOS was 3 (range 1–30) days.
Analysis of primary outcomes
Univariable and multivariable logistic regression analysis was
performed for the primary outcomes. Predictive factors for
complications, conversion and LOS are presented in
Tables 4, 5 and 6, respectively.
Univariable analysis showed that open surgery, large tu-
mour size and conversion to open surgery were associated
with an increased risk of complications. However, in the mul-
tivariable analysis, conversion from endoscopic to open sur-
gery was the only independent predictive factor for
Table 2 Results of preoperative
clinical variables for the patients
included in the study
n = 659 Percent
Age (median, year) 59 (8–89)
Female 372 (56.4)






Tumour size (median, mm) 35 (1–200)
Operation indication
Clinical syndrome of hormonal excess 399 (60.5)
Suspected malignancy on radiology 215 (32.6)
Suspected malignancy on cytology 27 (4.1)
Metastasis 32 (4.9)
Size only (≥40 mm) 75 (11.4)
Valid percent. Median (min-max)
BMI body mass index, n number
Table 3 Results of intra- and postoperative variables for the patients
included in the study





Histopathology (n = 528)
Malignant 71 (13.4)
Phaeochromocytoma 100 (18.9)
Other benign 357 (67.6)
Conversion 37 (5.6)
Complication
Bleeding with transfusion 17 (2.6)
Local infection/abscess 8 (1.2)
Pneumothorax 3 (0.5)
Laceration of viscus 5 (0.8)
Re-operation 10 (1.5)
30-day mortality 0 (0)
Length of hospital stay (median, days) 3 (1–30)
Valid percent. Median (min-max)
n number
Table 1 Distribution of patients between medical centres
n = 659 (%) Open Laparoscopic Robot
University hospital
1 235 (35.7) 8 55 172
2 179 (27.2) 30 72 77
3 143 (21.7) 33 109 1
4 62 (9.4) 16 46 0
5 20 (3.0) 4 16 0
County hospital
6 12 (1.8) 1 11 0
7 4 (0.6) 3 1 0
8 2 (0.3) 0 2 0
9 1 (0.15) 0 1 0
10 1 (0.15) 1 0 0
Valid percent
n number
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postoperative complications, OR 3.61 (CI 1.07–12.12). Open
surgery was also a risk factor when the surgical techniques
were grouped as endoscopic versus open technique, OR 2.26
(CI 1.03–4.93), but when the operations were divided into
laparoscopic, robotic and open surgery, the significance was
lost (Table 4).
The risk for conversion was increased in robotic-assisted
surgery, OR 5.14 (CI 1.46–18.11), in the univariable analysis.
However, in the multivariable analysis, only tumour size, OR
1.03 (CI 1.00–1.06), and malignant histopathology, OR 8.33
(CI 2.12–32.07), remained predictive (Table 5).
In the multivariable analysis of LOS, tumour on the left
side, OR 1.98 (CI 1.14–3.43), bilateral tumours, OR 3.13
(CI 1.08–9.06), open surgery, OR 115.18 (CI 32.94–402.67),
excess of cathecholamines, OR 2.32 (CI 1.18–4.59), and
conversion to open surgery, OR 42.05 (5.02–352.40), were
independent predictive factors for longer hospital stay
(Table 6).
Secondary outcomes
In the univariable analysis of patient characteristics and vari-
ables depending on the technique used, older age, large tu-
m o u r s i z e , m a l i g n a n t h i s t o p a t h o l o g y a n d
phaeochromocytoma were positively associated with open
surgery when compared with endoscopic surgery. A body
mass index of 25 or higher, left-sided tumours, and
hypercortisolism or aldosteronism were negatively associated
with open surgery.
Table 4 Uni- and multivariable regression analysis of risk factors for complication after adrenalectomy
Univariable logistic regression Multivariable logistic regression
n OR (95% CI) p n OR (95% CI) p
Age 658 1.02 (1.00–1.04) 0.109
Sex
Female 371 Ref
Male 287 1.38 (0.75–2.53) 0.295
BMI
<25 209 Ref.
≥25 372 0.73 (0.39–138) 0.336
Tumour side 0.603
Right 254 Ref.
Left 374 1.39 (0.73–2.64) 0.315
Bilateral 30 0.00 (0.00-.) 0.998
Largest tumour size 657 1.01 (1.01–1.02) <0.001
Surgical technique 0.001 0.112
Laparoscopic 262 Ref. 212 Ref.
Robotic 250 0.69 (0.30–1.56) 0.368 171 0.79 (0.33–1.92) 0.604
Open 146 2.61 (1.29–5.28) 0.007 84 2.03 (0.85–4.84) 0.109
Clinical syndrome of hormonal excess 0.157
None 260 Ref.
Cathecholamines 113 0.44 (0.16–1.17) 0.098
Cortisol 117 0.42 (0.16–1.13) 0.084
Aldosterone 161 0.62 (0.29–1.33) 0.222
Histopathology 0.178
Other benign 357 Ref.
Malignant 71 1.84 (0.79–4.31) 0.157
Phaeochromocytoma 100 0.61 (0.2–1.79) 0.364
Conversion
No 621 Ref. 449 Ref.
Yes 37 2.89 (1.14–7.34) 0.026 18 3.61 (1.07–12.12) 0.038
Complications that were analysed were bleeding with transfusion, laceration of viscus, pneumothorax, local infection or abscess and re-operation
analysed together
BMI body mass index, OR odds ratio, CI confidence interval, Ref. referent
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In multivariable logistic regression analysis, larger tumour
size OR 1.06 (CI 1.04–1.07) and malignant histopathology
OR 11.13 (CI 4.82–25.70) were positive predictive factors
for open surgery. (Suppl. Table 1 for the web).
When comparing robotic-assisted and laparoscopic adrenal-
ectomy, older age and larger tumour size were associated with
robotic-assisted adrenalectomy in the univariable analysis. In
the multivariable logistic regression analysis, older age, OR
1.02 (CI 1.00–1.03), was borderline significant and larger tu-
mour size, OR 1.02 (CI 1.01–1.03), remained the predictive
factor for robotic-assisted surgery. (Suppl. Table 2 for the web).
Discussion
In this national cohort of 659 patients undergoing adrenalec-
tomy, some 5.1% patients had at least one complication and
1.5% required re-operation. The only predictive factor associ-
ated with complications was conversion from endoscopic to
open surgery. In total, 5.6% of the procedures were converted
from endoscopic to open surgery and the risk for conversion
was related to larger tumour size and malignant tumours.
There were no in-hospital deaths and the 30-day mortality
was nil. Factors affecting LOS were left-sided tumour, bilat-
eral tumours, open surgery, excess of cathecholamines and
conversion to open surgery.
Laparoscopic adrenalectomy is the standard treatment for
adrenal tumours [4]. The technique has a low rate of compli-
cations, less postoperative pain, shorter LOS and lower mor-
bidity compared with open surgery [7, 14–16]. Laparoscopic
adrenalectomy is therefore cost-effective. There has been an
increase in adrenalectomy due to routine imaging and surgical
techniques. Benign disease or tumours of unclear significance
account for most of the increase [17]. The laparoscopic tech-
nique has evolved from transabdominal to posterior endo-
scopic and robotic-assisted surgery. Current studies recom-
mend open surgery in malignant or large tumours
(>100 mm) but some recent studies show equivalent results
for laparoscopic surgery regarding morbidity and mortality,
providing oncological principles are adhered to [18–21]. In
very large or locally invasive tumours, an open surgical ap-
proach is recommended to facilitate en bloc excision of the
Table 5 Uni- and multivariable logistic regression analysis of risk factors for conversion from endoscopic to open surgery
Univariable logistic regression Multivariable logistic regression
n OR (95% CI) p value n OR (95% CI) p value
Age 659 1.01 (0.99–1.04) 0.274
Sex
Female 372 Ref.
Male 287 1.11 (0.57–2.16) 0.762
BMI
<25 209 Ref.
≥25 373 1.07 (0.49–2.34) 0.869
Tumour side 0.387
Right 254 Ref.
Left 375 0.62 (0.31–1.23) 0.174
Bilateral 30 0.94 (0.21–4.25) 0.932
Largest tumour size 658 1.00 (0.99–1.01) 0.482 383 1.03 (1.00–1.06) 0.026
Surgical technique
Laparoscopic 263 Ref.
Robotic 250 5.14 (1.46–18.11) 0.011
Clinical syndrome of hormonal excess 0.030
None 260 Ref.
Cathecholamines 113 0.38 (0.13–1.12) 0.079
Cortisol 118 0.65 (0.27–1.56) 0.335
Aldosterone 161 0.20 (0.06–0.66) 0.009
Histopathology 0.208 0.005
Other benign 357 Ref. 291 Ref.
Malignant 71 2.44 (0.9–6.66) 0.081 24 8.33 (2.12–32.07) 0.002
Phaeochromocytoma 100 1.10 (0.35–3.46) 0.87 68 0.67 (0.08–5.73) 0.718
BMI body mass index, OR odds ratio, CI confidence interval, Ref. referent
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tumour [22]. It has therefore been recommended that these
patients should be treated in specialized centres in order to
improve outcomes [23, 24].
There are earlier reports concerning complications in adre-
nalectomy. Most of them compare outcomes following lapa-
roscopic versus open procedures and most of them are single
institution studies from tertiary centres. A lack of standardized
definition of complications influences the ability to compare
results. Eichhorn-Warry et al. used the Clavien-Dindo classi-
fication [25] and found that laparoscopic adrenalectomy de-
creased the use of intensive care for complications when com-
pared with open procedures [7]. There are only few retrospec-
tive, national investigations and none of them included all
hospitals that perform adrenalectomies [6, 11–13]. It is there-
fore interesting that the incidence of reported complications in
the literature in general is similar to what was shown in the
present study [1, 10, 11, 13, 26, 27]. In the present investiga-
tion, conversion to open surgery was the only independent
risk factor for complication. Although this could partly be
due to bias with larger tumours being at higher risk for con-
version, it could be of importance to consider when choosing
surgical technique for the individual patient. For some pa-
tients, an open approach may be preferred to endoscopic ad-
renalectomy. The proportion of open procedures in the present
report, 22.2%, is comparable with earlier studies [6, 7].
Bergamini et al., showed that age, BMI, tumour size and
phaeochromocytoma are risk factors for complications but
these in general were lower in referral than in non-referral
centres [11]. Surgeon volume influences outcome as well
and has been shown by Park et al. [28]. Furthermore, comor-
bidity has been associated with a risk for complications [1,
13]. These variables were not registered in the database used
Table 6 Uni- and multivariable logistic regression analysis of variables associated with postoperative length of stay
Univariable logistic regression Multivariable logistic regression
n OR (95% CI) p n OR (95% CI) p
Age 652 1.02 (1.01–1.03) 0.003
Sex
Female 368 Ref
Male 284 1.13 (0.82–1.55) 0.461
BMI
<25 208 Ref.
≥25 367 0.96 (0.68–1.35) 0.799
Tumour side 0.299 0.021
Right 253 Ref. 177 Ref.
Left 370 1.06 (00.76–1.47) 0.733 264 1.98 (1.14–3.43) 0.016
Bilateral 29 1.84 (0.85–3.99) 0.120 23 3.13 (1.08–9.06) 0.035
Largest tumour size 651 1.03 (1.03–1.04) <0.001
Surgical technique <0.001 <0.001
Laparoscopic 261 Ref. 211 Ref.
Robotic 250 1.72 (1.13–2.60) 0.011 171 1.56 (0.95–2.56) 0.081
Open 141 46.51 (23.84–90.72) <0.001 82 115.18(32.94–402.67) <0.001
Clinical syndrome of hormonal excess <0.001 0.012
None 255 Ref. 162 Ref.
Cathecholamines 113 1.03 (0.66–1.61) 0.884 84 2.32 (1.18–4.59) 0.015
Cortisol 116 1.06 (0.68–1.64) 0.805 86 1.56 (0.77–3.18) 0.219
Aldosterone 161 0.25 (0.16–0.41) <0.001 132 0.78 (0.40–1.51) 0.458
Histopathology <0.001
Other benign 356 Ref. <0.001
Malignant 70 5.09 (2.94–8.81) 0.006
Phaeochromocytoma 99 1.91 (1.21–3.03)
Conversion
No 617 Ref. 447 Ref.
Yes 35 14.18 (4.94–40.71) <0.001 17 42.05 (5.02–352.40) 0.001
Postoperative days before discharge, 1–3 (ref.) versus 4–30
BMI body mass index, OR odds ratio, CI confidence interval, Ref. referent
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for the present investigation, and therefore, the possible influ-
ence of these potential risk factors could not be evaluated.
Considering the well-known effects of hypercortisolism,
Cushing’s syndrome was expected as a risk factor for impaired
wound healing, bleeding and postoperative infection after ad-
renalectomy. However, this was not shown in the present study.
In contrast, Sommerey et al. found that bilateral adrenalectomy
for Cushing’s disease had more severe complications [29].
The conversion rate in the present study, 5.6%, was consis-
tent with previous reports [8, 10]. Bittner et al. collected data
retrospectively from 402 patients and found that tumour size
>80 mm was a predictive factor for conversion from endo-
scopic to open surgery [8]. This is comparable to the present
results and indicates that laparoscopic adrenalectomy is used
for increasingly larger lesions.
Length of hospital stay is similar in many reports and is
shorter after laparoscopic than open procedures [6, 8, 9, 13].
Independent predictive factors for risk for longer hospital stay
are not well explored. Of interest is that low surgeon volume and
some comorbidities are associated with higher LOS [1, 28].
However, these factors were not evaluated in the present study.
Almost half of the endoscopic operations in this cohort, 37.9%
in total, were robotic assisted. Robotic-assisted surgery was used
in older patients and more importantly in patients with larger
tumours. In the univariable analysis, therewas a tendency towards
a higher conversion rate compared with the standard laparoscopic
technique. However, this association was lost in the multivariable
analysis. Several retrospective studies on the use of robotic-
assisted adrenalectomy have been published during recent years
and all reported on small patient groups [30, 31]. In a meta-anal-
ysis, some advantages for robotic surgery comparedwith conven-
tional laparoscopic surgery were shown such as shorter hospital
stay, less intraoperative blood loss and lower risk for postoperative
complications [32]. However, given the scarce data, these results
should be interpreted with caution. The benefits of the robotic
technique in subtotal and bilateral adrenalectomy have been
discussed in a review article by Nomine-Criqui with equivocal
conclusions [33].
Hospital stay is one of the largest costs in health care.
Reports regarding costs associated with different surgical
techniques are scarce and most have small patient groups
[34, 35]. Given the higher cost for robotic surgery com-
pared with standard laparoscopy [31, 36], it remains to be
proven if the higher number of patients with large tumours
that are operated with robotic surgery instead of an open
approach could outweigh the increased costs for this new
technique.
In the present study, patients with left-sided tumours had a
longer hospital stay compared with patients operated for a
tumour on the right side. However, the results are not unequiv-
ocal. One study found a longer operative time for right-sided
tumours subjected to retroperitoneal endoscopic surgery [37].
Other investigations found no differences in outcome but
longer operation time [38] and increased risk for surgical com-
plications [10] in patients with left-sided tumours.
There are some limitations to the present study. The study
was based on results from a database with predefined data
fields, but data was analysed retrospectively. Although the
register is designed for the procedure, i.e. adrenalectomy, im-
portant variables such as comorbidity, previous abdominal
surgery, blood loss and operative time are missing. For non-
surgical complications, for instance pneumonia, venous
thrombosis and urinary tract infection, a free text field with
ICD coding is available in the database. However, it cannot be
ruled out that some of these complications were not coded.
Finally, the database does not identify outcomes for the indi-
vidual surgeon, which may affect the results.
The strength of the present study is that it involved one of
the largest national series of patients operated with adrenalec-
tomy. All hospitals that perform adrenal surgery in Sweden
participate in the registry and valid data are controlled regu-
larly by an extern audit.
Conclusion
Within the context of these limitations, the present study
shows a low risk for complications, a low conversion rate
from endoscopic to open surgery and a short hospital stay
for patients undergoing adrenalectomy in Sweden. The study
reinforces the benefits of minimal invasive surgery for adrenal
tumours on a national level.
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